Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Lagatie, Ole ^a   Van Loy, Tom ^a   Tritsmans, Luc ^b   Stuyver, Lieven J ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Biomarker; JC polyomavirus; Peptide serology; Progressive multifocal leukoencephalopathy; VP2

Indexed keywords

EPITOPE; PROTEIN VP2; BIOLOGICAL MARKER; PEPTIDE; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOREACTIVITY; JC POLYOMAVIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SEROLOGY; URINALYSIS; VIRUS INFECTION; VIRUS LOAD; AGED; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; IMMUNOLOGY; ISOLATION AND PURIFICATION; JC VIRUS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PROCEDURES; PROTEIN CONFORMATION; TUMOR VIRUS INFECTIONS; VIROLOGY; YOUNG ADULT;

JC POLYOMAVIRUS;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; JC VIRUS; MALE; MIDDLE AGED; MODELS, MOLECULAR; PEPTIDES; POLYOMAVIRUS INFECTIONS; PROTEIN ARRAY ANALYSIS; PROTEIN CONFORMATION; SEROLOGIC TESTS; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 84907815955     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-174     Document Type: Article

References (47)

1. Frisque RJ, Bream GL, Cannella MT: Human polyomavirus JC virus genome. J Virol 1984, 51(2):458-469.
2. Padgett BL, Rogers CM, Walker DL: JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships. Infect Immun 1977, 15(2):656-662.
3. Berger JR, Major EO: Progressive multifocal leukoencephalopathy. Semin Neurol 1999, 19(2):193-200.
4. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH: Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1(7712):1257-1260.
5. Dubois V, Dutronc H, Lafon ME, Poinsot V, Pellegrin JL, Ragnaud JM, Ferrer AM, Fleury HJ: Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997, 35(9):2288-2292.
6. Andreoletti L, Dubois V, Lescieux A, Dewilde A, Bocket L, Fleury HJ, Wattre P: Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy. Aids 1999, 13(12):1469-1475.
7. Weissert R: Progressive multifocal leukoencephalopathy. J Neuroimmunol 2011, 231(1-2):73-77.
8. Gasparovic ML, Gee GV, Atwood WJ: JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation. J Virol 2006, 80(21):10858-10861.
9. Shishido-Hara Y, Ichinose S, Higuchi K, Hara Y, Yasui K: Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol 2004, 78(18):9890-9903.
10. Giorda KM, Raghava S, Zhang MW, Hebert DN: The viroporin activity of the minor structural proteins VP2 and VP3 is required for SV40 propagation. J Biol Chem 2013, 288 (4):2510-2520.
11. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E: Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003, 71(1):115-123.
12. Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M: A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol 2013, 57(2):141-146.
13. Major EO: Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010, 61:35-47.
14. Van Loy T, Thys K, Tritsmans L, Stuyver LJ: Quasispecies analysis of JC virus DNA present in urine of healthy subjects. PLoS One 2013, 8(8):e70950.
15. Padgett BL, Walker DL: Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973, 127(4):467-470.
16. Taguchi F, Kajioka J, Miyamura T: Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982, 26(11):1057-1064.
17. Walker DL, Padgett BL: The epidemiology of human polyomaviruses. Prog Clin Biol Res 1983, 105:99-106.
18. Randhawa P, Viscidi R, Carter JJ, Galloway DA, Culp TD, Huang C, Ramaswami B, Christensen ND: Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol 2009, 90(Pt 3):634-639.
19. Viscidi RP, Clayman B: Serological cross reactivity between polyomavirus capsids. Adv Exp Med Biol 2006, 577:73-84.
20. Dominguez-Mozo MI, Garcia-Montojo M, De Las HV, Garcia-Martinez A, Arias-Leal AM, Casanova I, Arroyo R, Alvarez-Lafuente R: Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab. J Neuroimmune Pharmacol 2013, 8(5):1277-1286.
21. Plavina T, Berman M, Njenga M, Crossman M, Lerner M, Gorelik L, Simon K, Schlain B, Subramanyam M: Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma. J Clin Virol 2012, 53(1):65-71.
22. Warnke C, Pawlita M, Dehmel T, Posevitz-Fejfar A, Hartung HP, Wiendl H, Kieseier BC, Adams O: An assay to quantify species-specific anti-JC virus antibody levels in MS patients. Mult Scler 2013, 19(9):1137-1144.
23. Kean JM, Rao S, Wang M, Garcea RL: Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5(3):e1000363.
24. Moens U, Van Ghelue M, Song X, Ehlers B: Serological cross-reactivity between human polyomaviruses. Rev Med Virol 2013, 23(4):250-264.
25. Food-and-Drug-Administration: Anti-John Cunningham Virus (JCV) antibodies measured by Enzyme Linked Immunosorbent Assay (ELISA); 510(k) Number: K112394. 2012. [http://www.accessdata.fda.gov/cdrh-docs/reviews/K112394.pdf] webcite.
26. Zhang NN, Zhao LQ, Qian Y, Zhu RN, Deng J, Wang F, Sun Y, Liu LY: Common WU polyomavirus infection in a Beijing population indicated by surveillance for serum IgG antibody against capsid protein VP2. World J Pediatr 2013, 9(1):48-52.
27. Corallini A, Mazzoni E, Taronna A, Manfrini M, Carandina G, Guerra G, Guaschino R, Vaniglia F, Magnani C, Casali F, Dolcetti R, Palmonari C, Rezza G, Martini F, Barbanti-Brodano G, Tognon MG: Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol 2012, 73(5):502-510.
28. Mueller K, Schachtner T, Sattler A, Meier S, Friedrich P, Trydzenskaya H, Hinrichs C, Trappe R, Thiel A, Reinke P, Babel N: BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation 2011, 91(1):100-107.
29. Stuyver LJ, Verbeke T, Van Loy T, Van Gulck E, Tritsmans L: An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects. Virol J 2013, 10:192.
30. Cunningham BC, Wells JA: Comparison of a structural and a functional epitope. J Mol Biol 1993, 234(3):554-563.
31. Cunningham BC, Wells JA: High-resolution epitope mapping of hGHreceptor interactions by alanine-scanning mutagenesis. Science 1989, 244 (4908):1081-1085.
32. Zheng HY, Sugimoto C, Hasegawa M, Kobayashi N, Kanayama A, Rodas A, Mejia M, Nakamichi J, Guo J, Kitamura T, Yogo Y: Phylogenetic relationships among JC virus strains in Japanese/Koreans and Native Americans speaking Amerind or Na-Dene. J Mol Evol 2003, 56(1):18-27.
33. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215 (3):403-410.
34. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH: Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009, 199(6):837-846.
35. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, Neale RE: Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 2010, 91(Pt 7):1849-1853.
36. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J: Seroepidemiology of the human polyomaviruses. J Gen Virol 2003, 84(Pt 6):1499-1504.
37. Frohman EM, Monaco MC, Remington G, Ryschkewitsch C, Jensen PN, Johnson K, Perkins M, Liebner J, Greenberg B, Monson N, Frohman TC, Douek D, Major EO: JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab. JAMA Neurol 2014, 71(5):596-602.
38. Major EO, Frohman E, Douek D: JC viremia in natalizumab-treated patients with multiple sclerosis. N Engl J Med 2013, 368(23):2240-2241.
39. Major EO, Frohman E, Douek D: More on JC viremia in natalizumabtreated patients with multiple sclerosis. N Engl J Med 2013, 369(13):1280.
40. Berger JR, Houff SA, Gurwell J, Vega N, Miller CS, Danaher RJ: JC virus antibody status underestimates infection rates. Ann Neurol 2013, 74(1):84-90.
41. Diotti RA, Mancini N, Clementi N, Sautto G, Moreno GJ, Criscuolo E, Cappelletti F, Man P, Forest E, Remy L, Giannecchini S, Clementi M, Burioni R: Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy. Antivir Res 2014, 108:94-103.
42. Streckert HJ, Sommerfeld HJ, Morgenroth K, Werchau H: Recognition of SV40-VP2 in the infected cell by antipeptide antibodies. Arch Virol 1992, 123(3-4):399-407.
43. Chen XS, Stehle T, Harrison SC: Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J 1998, 17(12):3233-3240.
44. Burkert O, Kressner S, Sinn L, Giese S, Simon C, Lilie H: Biophysical characterization of polyomavirus minor capsid proteins. Biol Chem 2014, 395(7-8):871-880.
45. Lagatie O, Van Loy T, Tritsmans L, Stuyver LJ: Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects. Virol J 2014, 11(1):41.
46. Alland C, Moreews F, Boens D, Carpentier M, Chiusa S, Lonquety M, Renault N, Wong Y, Cantalloube H, Chomilier J, Hochez J, Pothier J, Villoutreix BO, Zagury JF, Tuffery P: RPBS: a web resource for structural bioinformatics. Nucleic Acids Res 2005, 33(Web Server issue):W44-W49.
47. Neron B, Menager H, Maufrais C, Joly N, Maupetit J, Letort S, Carrere S, Tuffery P, Letondal C: Mobyle: a new full web bioinformatics framework. Bioinformatics 2009, 25(22):3005-3011.